First Report on the Safety and Efficacy of a Long-Acting Recombinant FVIII (turoctocog alfa pegol, N8-GP) during Major Surgery in Patients with Severe Hemophilia a
- Resource Type
- Abstract
- Source
- In
Blood 3 December 2015 126(23):2283-2283 - Subject
- Language
- ISSN
- 0006-4971